Balchem Co. (NASDAQ:BCPC) is Montanaro Asset Management Ltd's 7th Largest Position

Montanaro Asset Management Ltd decreased its position in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 14.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 127,800 shares of the basic materials company's stock after selling 21,000 shares during the quarter. Balchem accounts for approximately 4.0% of Montanaro Asset Management Ltd's investment portfolio, making the stock its 7th largest holding. Montanaro Asset Management Ltd owned 0.39% of Balchem worth $22,493,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. raised its position in Balchem by 3.8% during the first quarter. Vanguard Group Inc. now owns 3,935,935 shares of the basic materials company's stock valued at $609,873,000 after acquiring an additional 144,423 shares in the last quarter. Conestoga Capital Advisors LLC raised its position in Balchem by 1.8% during the third quarter. Conestoga Capital Advisors LLC now owns 1,175,569 shares of the basic materials company's stock valued at $206,900,000 after acquiring an additional 20,360 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Balchem by 0.9% during the second quarter. Dimensional Fund Advisors LP now owns 697,461 shares of the basic materials company's stock valued at $107,372,000 after acquiring an additional 5,977 shares in the last quarter. Congress Asset Management Co. raised its position in Balchem by 12.4% during the third quarter. Congress Asset Management Co. now owns 301,440 shares of the basic materials company's stock valued at $53,053,000 after acquiring an additional 33,373 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in Balchem by 1.2% during the second quarter. Bank of New York Mellon Corp now owns 277,475 shares of the basic materials company's stock valued at $42,717,000 after acquiring an additional 3,279 shares in the last quarter. Institutional investors and hedge funds own 87.91% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on BCPC. HC Wainwright lifted their price target on Balchem from $185.00 to $190.00 and gave the company a "buy" rating in a research report on Monday, November 4th. StockNews.com upgraded Balchem from a "hold" rating to a "buy" rating in a research report on Monday, October 28th.

Balchem Price Performance

Shares of Balchem stock traded up $2.69 on Friday, reaching $179.32. The company's stock had a trading volume of 135,783 shares, compared to its average volume of 122,450. The company has a market capitalization of $5.83 billion, a P/E ratio of 48.20, a PEG ratio of 5.48 and a beta of 0.65. Balchem Co. has a 52-week low of $116.84 and a 52-week high of $186.03. The stock has a 50-day moving average price of $172.12 and a 200-day moving average price of $164.24. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.